Skip to main content

Table 1 Pathological type distribution of epithelial ovarian carcinoma patients

From: Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study

Category

Pathology staging

 

I

II

III

IV

Total

Serous cystadenocarcinoma

15(7.8)

23(12.0)

145(75.5)

9(4.7)

192(56.1)

Mucinous cystadenocarcinoma

9(34.6)

3(11.5)

14(53.9)

0(0)

26(7.6)

Endometrial adenocarcinoma

11(34.4)

5(15.6)

16(50.0)

0(0)

32(9.4)

Clear cell carcinoma

19(82.6)

0(0)

4(17.4)

0(0)

23(6.7)

Mixed type and undifferentiated carcinoma

26(37.7)

24(34.8)

19(27.5)

0(0)

69(20.2)

Total

80(23.4)

55(16.1)

198(57.9)

9(2.6)

342(100.0)